Top news of the week: 10.06.2022.
Opinion: Here’s how San Diego biotech helped fight the COVID-19 pandemic
Countless academic and research institutions, companies and organizations working on life sciences and biotechnology are woven into the city’s fabric
Aurion Biotech Appoints Dr. Michael Goldstein as President and Chief Medical Officer
Leading Ophthalmologist and Experienced Industry Executive to Advance Development of Innovative Corneal Endothelial Cell TherapySEATTLE, BOSTON & TOKYO--(BUSINESS WIRE)--Aurion Biotech, ...
PharmaCyte Biotech Issues Response to Iroquois Capital Letter and Announces Additional Steps to Increase Shareholder Value
LAS VEGAS--(BUSINESS WIRE)--PharmaCyte Biotech, Inc. (NASDAQ: PMCB) (PharmaCyte), a biotechnology company focused on developing cellular therapies for cancer, diabetes, and malignant ...
Ambrx Biopharma Inc. Appoints Janet Loesberg to Board of Directors
SAN DIEGO--(BUSINESS WIRE)-- Ambrx Biopharma Inc., or Ambrx, (NYSE: AMAM), a clinical stage biopharmaceutical company using an expanded genetic code technology platform to create ...
It's Who You Know: A Guide to Career Networking in the Life Science Industry
Even if you aren’t looking for a new role in biopharma, nurturing relationships will only benefit your current role. Use these easy ways to improve your career networking skills.
#BIO22: BIO chair Paul Hastings: 'I think people should speak their truth'
Paul Hastings doesn't offer the usual biotech executive cliches. The ones endorsed by the media consultant crowd. And sometimes the Nkarta CEO doesn't even wait for a question before ...
Aslan, Yumanity, Editas, Janssen and More Team Up to Fight Disease
Aslan partners with Johns Hopkins and Duke, Editas joins forces with Immatics, Yumanity (soon to be Kineta, Inc.) teams with Janssen, Serotiny & Janssen Biotech and Ginkgo and Novo Nordisk.
GSK declares a big win with positive topline results for its adult RSV vaccine. But the jury still out on bottom line efficacy
Emma Walmsley's bet on making GSK a pure play Big Pharma innovator just cleared a major milestone. But the GSK team is not home free yet. The global player announced that its adult RSV ...